Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.

SILVIA SÁNCHEZ PUCH; CLAUDIA OCHOA; GUADALUPE CARBALLAL; CARLOS ZALA; PEDRO CAHN; ROSARIO BRUNET; HORACIO SALOMÓN; CRISTINA VIDELA

JOURNAL OF CLINICAL VIROLOGY : THE OFFICIAL PUBLICATION OF THE PAN AMERICAN SOCIETY FOR CLINICAL VIROLOGY.

ELSEVIER SCIENCE BV

Lugar: Amsterdam; Año: 2004 vol. 30 p. 271 - 275

1386-6532

Prolonged therapy with ganciclovir (GCV) can result in the development of GCV-resistant strains due to mutations in the viral phosphotransferase (UL97 gene) and/or in the viral DNA polymerase (UL54 gene).Objectives: The purpose of this study was to detect by molecular methods the most prevalent UL97 mutants which confer ganciclovir-resistance in immunocompromised populations. Study design: Patients from two populations were selected: (a) renal transplant patients with active cytomegalovirus (CMV) infection and more than one cycle of GCV; (b) HIV-infected patients with retinitis due to CMV, who were under GCV induction, maintenance therapy or withdrawal. Patients were followed up by pp65 antigenemia and by viral isolation from blood or/and urine samples. Two fragments (133 and 255 pb) of the UL97 gene were amplified by polymerase chain reaction (PCR) from CMV isolates. Results: Nine from 12 isolates obtained were sequenced, three from two renal transplant patients and six from five HIV-infected patients. A UL97 mutation, known to confer GCV resistance, was found in two isolates from a renal transplant patient. A methionine to valine mutation at codon 460 (M460V) was detected. These isolates exhibited another mutation at codon 605, whose amino acid changed from aspartic acid (D) to glutamic acid (E). These findings were observed after treatment with IV-GCV/ O-GCV/ IV-GCV for 151 days. The 605 mutation was also detected in leukocytes from the same patient previous to the beginning of the treatment with GCV. Conclusions: Although a known resistant mutation appeared in a renal transplant patient, it was not associated with CMV disease. We suggest that the D605E mutation could ?partially or totally compensate? for the effect of GCV resistance conferred by the 460 mutation. Further studies should be performed to confirm this hypothesis.